Please sign in to follow a disease.
Bile duct neoplasm
MONDO:0021662A benign or malignant neoplasm that affects the intrahepatic or extrahepatic bile ducts. Representative examples of benign neoplasms include bile duct adenoma and extrahepatic bile duct lipoma. Representative examples of malignant neoplasms include intrahepatic and extrahepatic cholangiocarcinoma.
Also known as: bile duct neoplasm, bile duct neoplasm (disease), bile duct tumor, bile duct tumour, intrahepatic and extrahepatic bile duct neoplasm, intrahepatic and extrahepatic bile duct tumor, intrahepatic and extrahepatic bile duct tumour, neoplasm of bile duct
1911 clinical trials for this condition and its sub-types, 41 tagged with Bile duct neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Bile duct neoplasm
-
Bile duct cancer 34 trials · 468 incl. sub-types
4 sub-types
- Bile duct carcinoma 20 trials · 451 incl. sub-types Sub-types →
- Malignant tumor of extrahepatic bile duct 1 trial · 431 incl. sub-types Sub-types →
- Intrahepatic bile duct cancer 6 trials · 176 incl. sub-types Sub-types →
- Bile duct sarcoma 0 trials Sub-types →
-
Extrahepatic bile duct neoplasm 0 trials · 431 incl. sub-types
7 sub-types
- Malignant tumor of extrahepatic bile duct 1 trial · 431 incl. sub-types Sub-types →
- Carcinoma of gallbladder and extrahepatic biliary tract 1 trial · 371 incl. sub-types Sub-types →
- Common bile duct neoplasm 2 trials · 71 incl. sub-types Sub-types →
- Extrahepatic bile duct adenoma 0 trials Sub-types →
- Extrahepatic bile duct leiomyoma 0 trials
- Extrahepatic bile duct lipoma 0 trials
- Gallbladder neuroendocrine tumor, grade 1/2 0 trials
-
Bile duct adenoma 0 trials
3 sub-types
- Bile duct cystadenoma 0 trials Sub-types →
- Extrahepatic bile duct adenoma 0 trials Sub-types →
- Intrahepatic bile duct adenoma 0 trials Sub-types →
-
Bile duct papillary neoplasm 0 trials
3 sub-types
- Extrahepatic bile duct papillary adenoma 0 trials
- Extrahepatic biliary papillomatosis 0 trials
- Intrahepatic biliary papillomatosis 0 trials
Most studied deeper sub-types
-
Which stent lasts longest? a Head-to-Head test for bile duct blockage
Disease control OngoingThis trial is testing three types of metal stents used to relieve jaundice in people with advanced cancer blocking the bile duct. The stents – uncovered, partially covered, or fully covered – are placed during an endoscopic procedure to keep the duct open. The study will compare …
Sponsor: Region Stockholm • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New cocktail of drugs shows promise for Tough-to-Treat bile duct cancer
Disease control OngoingThis study tests a combination of four drugs (gemcitabine, cisplatin, quemliclustat, and zimberelimab) as a first treatment for people with advanced biliary tract cancers, including bile duct cancer. The goal is to see if this mix can slow cancer growth and help people live longe…
Phase 2 • Sponsor: Nataliya Uboha • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Chemotherapy sprayed directly into the abdomen: a new attack on stubborn cancers
Disease control OngoingThis phase 1 trial tests a new method of delivering chemotherapy for people with cancers that have spread to the lining of the abdomen (peritoneal carcinomatosis) from gastrointestinal cancers like colorectal, stomach, or pancreatic cancer. The drug, nanoliposomal irinotecan (Oni…
Phase 1 • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug aims to stop bile duct cancer from returning after surgery
Disease control OngoingThis global phase 3 trial is testing whether adding the immunotherapy drug rilvegostomig to standard chemotherapy can help prevent biliary tract cancer from coming back after surgery. About 757 people who had their cancer completely removed will receive either rilvegostomig or a …
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for bile duct cancer: targeted drug shows promise in early trial
Disease control OngoingThis study tests a drug called olaparib in 32 people with advanced bile duct cancer that has spread and has certain DNA repair gene mutations. Olaparib works by blocking enzymes that cancer cells need to grow. The main goal is to see how many patients are alive without their canc…
Phase 2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Keytruda takes on 15 advanced cancers in major trial
Disease control OngoingThis phase 2 trial tests the immunotherapy drug pembrolizumab (Keytruda) in people with 15 types of advanced solid tumors that have worsened after standard treatments. About 1,600 participants receive the drug to see if their tumors shrink or stop growing. The study also looks fo…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New PET scan aims to spot hidden cancers with precision
Diagnosis OngoingThis study tests a special PET scan that uses a radioactive antibody (64Cu-M5A) to find cancers that produce a protein called CEA. The goal is to see if this scan can detect tumors that standard methods might miss. About 20 adults with CEA-positive cancers (such as breast, colon,…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
Cancer tissue bank aims to fuel future discoveries
Knowledge-focused OngoingThis study collects leftover tissue, blood, and other fluid samples from 6,000 people with benign or malignant tumors of the soft tissue, gastrointestinal tract, or abdomen. Researchers will use these samples in lab studies to better understand the causes, prevention, diagnosis, …
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC